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  The clinical effectiveness of Cefotaxime， a new antibiotic， was studied in 18 cases of cemplicated
urinary tract infection． The drug was given圭n doses of 2 to 6 g， twice or thrce times a day by intra－
venous drip infusion for 3 to 9 days．
  The results are summarized as follows；
i． As to the overall clinical effectivenesg． based on the UTI efficacy evaluation standards， the response
 was excellcnt in l I O／． （2 out of 18 cases）， moderate in 500／， （9 cases）， and poor in 390／o （7 cases）．
 Pyuria was cleared in 220／．， decreased in 110／，， and unchanged in 670／．． Bacteriuria was eliminated
 in 610／， and unchanged in S90／． （Table 2）．
2． The overali clinical effectiveness for the group without indwelling catheters （group 3） was better
 than that for the group， without indwelling catheters （groups 1 and 5） （Table 3）．
8． As to the bacteriological response to Cefotaxirne， 25 out of the 35 strains isolated （710／．） were
 eradicated， and 10 （290／．） persisted （Table 4）．
4． No marked adverse reaction was observed．
  From the above results， Cefotaxime’was suggested to be a usefu1 antibiotic in the treatment of
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15 67 M bladdertumor 皿 2x2；．v．
7
5
・14 48 F ．pyelonephrltisVUR 皿 1x2i．v． 6
15 70 M pyelonephritlsbladder tumor 皿 2x2i．v． 10
16 50 M prostatitisprostotic stone  十ur thra1 2x2i．v． 3
17 op M pyonefSlro＄ispolycystic kld． ney 皿 2x2i．v． 7
18 48 F pyelonephritishydronephrosis
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urethrav 2．x2 Lv． 5
＊」一止   After treatrnent
                           郡・ほか
rJTI cases treated with cefptaxime
：複雑性尿路感染症・CefotaXime
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Table 2．cverall clinical eflicacy of cefotaxime
in complicated U．T．1




EIiminG†ed団 2 7 日｛61％｝DecreGsed
Replqced
Unchoged 2 5 7〔59％1
Erficocy on






2” 1 ele l
9 （50 e！．）
7 （5 9 01eJ
Overol 1 effectiveness rQte



















例（80％），C． frenndii 4例中3例（75％）． Ps． aerugi－
nosa 6例申4例（67％）などで，全菌種についても
7LO％と高率であった．但有効率が低い菌はEnter．
Table 3． Overall clinical eMcacy of cefotaxime classified by type of infection
Group 蓉＆81（：襯DExce口en十  Modero十e   OverG目Poor effectiveness
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Totai 18 ｛ 1 oo ol， ） 2 9 7 61 010
郡・ほか』：複雑性尿路感染症・Cefotaxime
Table 4． Bacteriological response to cefotaxime
    in complicated U．T．1
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